|

Zinc-64 Aspartate Clinical Trials

1 actively recruiting trial

Also known as: KLS-1

Pipeline

Phase 1/2: 1

Top Sponsors

  • Vector Vitale LLC1

Indications

  • CLL1
  • Solid Tumor, Adult1
  • Cancer1

Other1 trial

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.